Report period | 2017 | 2018 | 2019 | 2020 | 2021 | Q1 22 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, £ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Company name | GSK |
---|---|
Tags | #pharmacy |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
Business address | 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000 |
Mailing address | 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS |
Website | www.gsk.com |